Market Size of Vitrectomy Devices Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 7.40 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Vitrectomy Devices Market Analysis
The Vitrectomy Devices Market is expected to register a CAGR of 7.4% over the forecast period.
The COVID-19 pandemic initially had a significant impact on the market for vitrectomy devices. As a safety response to the pandemic, hospitals worldwide reduced in-person checkups in outpatient departments to maximize the use of resources on the front to manage the pandemic. According to a cross-sectional study of 526,536 procedures across 17 institutions published in JAMA Ophthalmol 2021, there was a significant decrease in the use of lasers and cryotherapy, retinal detachment repairs, and other vitrectomies from mid-March 2020 to at least May 2020. Moreover, ophthalmology has been one of the most severely impacted specialties regarding patient numbers and surgeries, owing to a long waiting time and a fear among patients visiting medical facilities. However, the American Academy of Ophthalmology (AAO) indicated that urgent or emergent vitreoretinal surgical procedures should continue during the COVID-19 pandemic. Thus, the COVID-19 outbreak affected the market's growth adversely in its preliminary phase; however, the market gained traction due to the normalcy in the number of vitrectomy surgeries globally.
Further, the increasing prevalence of diabetic retinopathy and retinal detachment and technological advances in vitrectomy procedures are among the major factors driving the growth of the market studied. According to the International Agency for the Prevention of Blindness (IAPB), approximately 93 million people globally have diabetic retinopathy. In addition, about 1 in 3 people with diabetes have some degree of diabetic retinopathy, and 1 in 10 are anticipated to develop a vision-threatening form of the disease. Such factors will likely boost the demand for vitrectomy devices, thereby contributing to the growth of the market studied.
According to the IDF, in 2021, approximately 537 million adults (20-79 years of age) were living with diabetes. In addition, it is anticipated that the total number of people living with diabetes will rise to 643 million by 2030 and 783 million by 2045. Furthermore, the Vision Loss Expert Group, a part of the IAPB Organization, estimated that in 2020, 1 million people were blind globally due to diabetic retinopathy, and over 3 million had moderate-to-severe vision impairment. Moreover, increasing screening for diabetic retinopathy and an increasing number of campaigns raising awareness of diabetic retinopathy is also driving the market growth. For instance, in November 2022, the All India Ophthalmological Society (AIOS) and Vitreo-Retinal Society of India (VRSI) commemorated World Diabetes Day by organizing a walking marathon to raise awareness for diabetic retinopathy. Thus, the increasing prevalence of diabetic retinopathy and retinal detachment is poised to accelerate the vitrectomy devices market globally and is expected to increase in the future, thereby driving the growth of the studied market over the forecast period.
Therefore, owing to the factors mentioned above, it is anticipated that the market studied will witness growth over the analysis period. However, patient discomfort and risks associated with the vitrectomy procedure are likely to impede the market's growth.
Vitrectomy Devices Industry Segmentation
Vitrectomy is an eye surgery used to remove some or all of the vitreous humor from the eye. It involves making a small cut (incision) or using special blades to insert the instruments into the sclera of the eyes.
The Vitrectomy Devices Market is Segmented by Product Type (Vitrectomy System, Illumination Devices, Infusion Devices, Instruments, and Other Product Types), Application (Diabetic Retinopathy, Retinal Detachment, Macular Hole, Vitreous Hemorrhage, and Other Applications), End-User (Hospitals, Ophthalmology Clinics, and Ambulatory Surgical Centers), and Geography (North America (United States, Canada, Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Middle East and Africa GCC, South Africa, and Rest of the Middle East and Africa), and South America (Brazil, Argentina, Rest of South America)). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Product Type | |
Vitrectomy System | |
Illumination Devices | |
Infusion Devices | |
Instruments | |
Other Product Types (Visualization Devices, Photocoagulation Devices, Cryotherapy Devices) |
By Application | |
Diabetic Retinopathy | |
Retinal Detachment | |
Macular Hole | |
Vitreous Hemorrhage | |
Other Applications (Vitreous floaters, Macular Pucker) |
By End-Users | |
Hospitals | |
Ophthalmology Clinics | |
Ambulatory Surgical Centers |
By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Vitrectomy Devices Market Size Summary
The vitrectomy devices market is poised for significant growth, driven by the increasing prevalence of diabetic retinopathy and retinal detachment, alongside technological advancements in vitrectomy procedures. The market experienced an initial setback due to the COVID-19 pandemic, which led to a reduction in elective surgeries and outpatient visits. However, the resumption of normalcy in surgical procedures has spurred market recovery. The demand for vitrectomy devices is further bolstered by the rising incidence of diabetes-related eye conditions, with global awareness campaigns and screening initiatives playing a crucial role in market expansion. Technological innovations, such as high-speed vitrectomy systems and miniaturized surgical instruments, are enhancing the efficiency and safety of procedures, thereby increasing their adoption among healthcare professionals.
North America is expected to lead the market, supported by the availability of advanced medical technologies, a high prevalence of eye disorders, and a well-established healthcare infrastructure. The region benefits from a concentration of key market players and continuous product innovations, such as the FDA-approved ZEISS QUATERA 700 system, which enhances surgical workflow efficiency. The competitive landscape is characterized by a few dominant companies, including Alcon, Bausch Health Companies Inc., and Johnson & Johnson, which hold significant market shares. These companies are actively engaged in product development and strategic collaborations to maintain their market positions. Despite the market's growth prospects, challenges such as patient discomfort and procedural risks may impede further expansion.
Vitrectomy Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Prevalence of Diabetic Retinopathy and Retinal Detachment
-
1.2.2 Technological Advances in Vitrectomy Procedures
-
-
1.3 Market Restraints
-
1.3.1 Patient Discomfort and Risks Associated with the Vitrectomy Procedure
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product Type
-
2.1.1 Vitrectomy System
-
2.1.2 Illumination Devices
-
2.1.3 Infusion Devices
-
2.1.4 Instruments
-
2.1.5 Other Product Types (Visualization Devices, Photocoagulation Devices, Cryotherapy Devices)
-
-
2.2 By Application
-
2.2.1 Diabetic Retinopathy
-
2.2.2 Retinal Detachment
-
2.2.3 Macular Hole
-
2.2.4 Vitreous Hemorrhage
-
2.2.5 Other Applications (Vitreous floaters, Macular Pucker)
-
-
2.3 By End-Users
-
2.3.1 Hospitals
-
2.3.2 Ophthalmology Clinics
-
2.3.3 Ambulatory Surgical Centers
-
-
2.4 By Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle-East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Vitrectomy Devices Market Size FAQs
What is the current Vitrectomy Devices Market size?
The Vitrectomy Devices Market is projected to register a CAGR of 7.40% during the forecast period (2024-2029)
Who are the key players in Vitrectomy Devices Market?
Alcon, Bausch Health Companies Inc., BVI, DORC Holding B.V. and Johnson & Johnson are the major companies operating in the Vitrectomy Devices Market.